Original Research on Real-World Outcomes of Anticoagulation and Corticosteroid in COVID-19,” published in the February 2025 ...

The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

A study on bat genomes, involving Texas Tech University, discovered genetic adaptations that help bats resist viral ...

As in adults, delirium and dementia can mimic psychotic phenomena. Fortunately, dementia is very rare in this age group, and the clinical picture is then one of progressive deterioration without ...

This study found that people with long COVID who followed a Mediterranean diet eating pattern had lower levels of uric acid, ...

Long COVID can make life uncomfortable for COVID patients even years after they recover. And there's a common sleep disorder ...

We expect modern medicine to be able to make sense of our health difficulties. What then, when it fails to do so for people ...

A 22-year-old Omaha woman has been attending a long COVID program at Madonna Rehabilitation for months after contracting the virus multiple times while working as a certified nursing assistant.

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

Microbiome as a Potential Key to Better Treatment: Clinical Study on New Therapy for Crohn's Disease Feb. 11, 2025 — A special liquid diet, known as exclusive enteral nutrition, is an essential ...